Molecular Fingerprint Of Breast Cancer Drug Resistance Can Predict Response To Treatment

A way of predicting which patients will respond well to treatment with a common chemotherapy drug used in breast cancer was unveiled at the European Cancer Conference (ECCO 14). Dr Iain Brown, from the University of Aberdeen, Aberdeen, Scotland, told the conference that he and his colleague, Dr Andrew Schofield, had identified two genes that could identify which cells would be resistant and which would respond to docetaxel. [click link for full article]

More: continued here

Filed under: Breast Cancer on September 26th, 2007